JNJ-26481585 Size:2mg solid D-erythro-Sphingosine has been shown to

D-erythro-Sphingosine has been shown to inhibit protein kinase C

Chemical Name: 5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-(((2S

type I) mediated lipid transfer

PubMed PMID: 23907354

InChiKey: GXCGXOBFROXMLV-UHFFFAOYSA-N

JNJ-26481585 Size:2mg solid D-erythro-Sphingosine has been shown toQuisinostat (USAN; development code JNJ 26481585) is an experimental drug candidate for the treatment of cancer. It is a "second generation" histone deacetylase inhibitor with antineoplastic activity. It is highly potent against class I and II HDACs. Product information CAS Number: 875320 29 9 Molecular Weight: 394. 47 Formula: C21H26N6O2 Synonym: Quisinostat Related CAS Number: 1083078 98 1 (Quisinostat hydrochloride) 875320 31 3 (Quisinostat